You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Golimumab for treating non-radiographic axial spondyloarthritis

  • Technology appraisal guidance
  • Reference number: TA497
  • Published:  10 January 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination: 1
  3. Draft scope documents
  4. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 220 KB)

    Published:
    10 January 2018
  • Equality Impact Assessment (Guidance development) (PDF 220 KB)

    Published:
    10 January 2018

Final appraisal determination: 1

  • Final appraisal determination: 1

  • Committee papers (PDF 3.31 MB)

    Published:
    16 November 2017
  • Final appraisal determination document (PDF 303 KB)

    Published:
    16 November 2017
  • Public committee slides (PDF 549 KB)

    Published:
    16 November 2017

Draft scope documents

  • Draft scope (pre-referral) (PDF 109 KB)

    Published:
    15 April 2016
  • Provisional matrix (pre-referral) (PDF 37 KB)

    Published:
    15 April 2016

Invitation to participate

  • Final scope (PDF 211 KB)

    Published:
    04 April 2017
  • Final matrix (PDF 287 KB)

    Published:
    04 April 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 198 KB)

    Published:
    04 April 2017
Back to top